RS50274B - Ob polypeptide and its diagnostic and therapeutic use - Google Patents

Ob polypeptide and its diagnostic and therapeutic use

Info

Publication number
RS50274B
RS50274B YU54995A YU54995A RS50274B RS 50274 B RS50274 B RS 50274B YU 54995 A YU54995 A YU 54995A YU 54995 A YU54995 A YU 54995A RS 50274 B RS50274 B RS 50274B
Authority
RS
Serbia
Prior art keywords
polypeptide
seq
diagnostic
body weight
amino acid
Prior art date
Application number
YU54995A
Other languages
Serbian (sr)
Inventor
Jeffrey M. Friedman
Yiying Zhang
Margherita Maffei
Jeffrey L. Halaas
Ketan Gajiwala
Stephen K. Burley
Ricardo Proenca
Original Assignee
The Rockefeller University,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/292,345 external-priority patent/US6001968A/en
Priority claimed from US08/438,431 external-priority patent/US6429290B1/en
Priority claimed from US08/483,211 external-priority patent/US6309853B1/en
Application filed by The Rockefeller University, filed Critical The Rockefeller University,
Publication of YU54995A publication Critical patent/YU54995A/en
Publication of RS50274B publication Critical patent/RS50274B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Abstract

OB polipeptid, naznačen time, što je odabran iz grupe koju čine: a) polipeptid čija je aminokiselinska sekvenca SEQ ID NO.2,4,5 ili 6; b) biološki aktivni fragment polipeptida iz (a) gde dati fragment modulira telesnu težinu životinje; c) polipeptid iz a) ili b) kod koga su izostavljene ili supstituisane aminokiseline na pozicijama koje ne utiču na strukturu ili funkciju polipeptida; d) OB polipeptid sposoban da modulira telesnu težinu, čija je sekvenca 83% ili više homologna sa OB polipeptidom čija je aminokiselinska sekvenca SEQ ID NOS. 2,4,5 ili 6; e) hemijski modifikovan polipeptid iz (a) do (d), tako što je za polipeptid vezana jedna ili više hemijskih grupa. Prijava sadrži još 14 nezavisnih i 30 zavisnih patentnih zahteva.OB polypeptide selected from the group consisting of: a) a polypeptide having the amino acid sequence of SEQ ID NO.2,4,5 or 6; b) a biologically active fragment of the polypeptide of (a) wherein said fragment modulates the body weight of the animal; c) a polypeptide of a) or b) wherein the amino acids are omitted or substituted at positions that do not affect the structure or function of the polypeptide; d) an OB polypeptide capable of modulating body weight, the sequence of which is 83% or more homologous to the OB polypeptide whose amino acid sequence is SEQ ID NOS. 2,4,5 or 6; e) a chemically modified polypeptide of (a) to (d) such that one or more chemical groups are attached to the polypeptide. The application contains 14 more independent and 30 dependent patent claims.

YU54995A 1994-08-17 1995-08-17 Ob polypeptide and its diagnostic and therapeutic use RS50274B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/292,345 US6001968A (en) 1994-08-17 1994-08-17 OB polypeptides, modified forms and compositions
US08/347,563 US5935810A (en) 1994-08-17 1994-11-30 Mammalian ob polypeptides capable of modulating body weight, corresponding nucleic acids, and diagnostic and therapeutic uses thereof
US08/438,431 US6429290B1 (en) 1994-08-17 1995-05-10 OB polypeptides, modified forms and derivatives
US08/483,211 US6309853B1 (en) 1994-08-17 1995-06-07 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof

Publications (2)

Publication Number Publication Date
YU54995A YU54995A (en) 1998-05-15
RS50274B true RS50274B (en) 2009-07-15

Family

ID=46507740

Family Applications (1)

Application Number Title Priority Date Filing Date
YU54995A RS50274B (en) 1994-08-17 1995-08-17 Ob polypeptide and its diagnostic and therapeutic use

Country Status (5)

Country Link
KR (1) KR100584177B1 (en)
BR (1) BRPI9508596B1 (en)
PE (1) PE47396A1 (en)
RS (1) RS50274B (en)
UA (1) UA70911C2 (en)

Also Published As

Publication number Publication date
KR100584177B1 (en) 2006-10-24
KR970705631A (en) 1997-10-09
YU54995A (en) 1998-05-15
PE47396A1 (en) 1996-12-02
UA70911C2 (en) 2004-11-15
BRPI9508596B1 (en) 2018-11-27

Similar Documents

Publication Publication Date Title
ATE60980T1 (en) NEW VARIETY OF BACILLUS THURINGIENSIS EFFECTIVE AGAINST COLEOPTERA AND AN INSECTICIDAL PREPARATION AVAILABLE THEREOF. TOXIN AND ITS USE TO COMBAT COLEOPTERA.
PT839196E (en) CTLA-8 HUMAN AND CTLA-8 RELATED PROTEIN UTILIZATIONS
RS51898B (en) Specific binding agents of human angiopoietin-2
ES2140082T3 (en) PEPTIDE COMPOSITIONS WITH ACTIVITY OF A GROWTH FACTOR TYPE.
ES2081370T3 (en) GENE AND PROTEIN OF BACILLUS THURINGIENSIS, AND ITS USE.
BR9713108A (en) Recombinant clostridium histolytucum type i collagenase and its use for cell and cell group isolation
BR9206578A (en) Sequence of synthetic DNA having improved insecticidal activity in corn.
DK0690872T3 (en) Biologically active peptides from bacterial / permeability enhancing protein functional domains and uses thereof
DE69942035D1 (en) HUMAN PARATHYROIDHORMONE, MODIFICATIONS, MANUFACTURE AND USE
DE69824755D1 (en) Mammalian cytokine-like polypeptide-10
ES2171417T3 (en) USE OF BACILLUS THURINGIENSIS ISOLATED TO CONTROL PESTS OF THE APHIDIDAE FAMILY.
DE69920877D1 (en) ANTIMICROBIALLY EFFECTIVE PEPTIDES
PT851926E (en) RANGE INTERFERENCE VARIABLES (RHU-IFN-RANGE) HUMAN RECOMBINANT WITH ENHANCED THERMAL STABILITY
SE9101838D0 (en) NOVEL PEPTIDES AND THEIR USE
DK0896615T3 (en) Soluble Peptide of Acetylcholinesterase Active as Calcium Channel Modulator
ES2129456T3 (en) PROCEDURE FOR THE CONTROL OF PESTS OF LEPIDOPTERS.
ATE378408T1 (en) MAMMAL TRANSFORMING GROWTH FACTOR BETA-9 (ZTGFSS9).
DE68917837T2 (en) Peptide compounds.
RS50831B (en) An isolated antibody or antibody fragment which specifically binds to the rg1 polypeptide
RS50274B (en) Ob polypeptide and its diagnostic and therapeutic use
RS49520B (en) Antimicrobially active mixtures
ATE432985T1 (en) POLYPEPTIDES WITH NEUTROPHIL STIMULATING ACTIVITY
ES2097368T3 (en) NEW TROMBINE INHIBITOR PROTEINS FROM SANGUIJUELAS TERRESTRES.
ES2097931T3 (en) NEW THROMBIN INHIBITING PROTEIN FROM HUNTING BEDS.
BR9604843A (en) Peptide and derivative thereof, and drug and composition to treat osteopathy